News & Stories

The Hong Kong University of Science and Technology (HKUST) announced today that  its School of Engineering researchers have developed Mixture of Modality Experts (MOME), a groundbreaking large artificial intelligence (AI) model for non-invasive breast cancer diagnosis. Trained on the China’s largest multiparametric MRI (mpMRI) breast cancer dataset, MOME achieves expert-level accuracy in classifying tumor malignancy, comparable to that of radiologists with five+years of experience. This innovative solution is now undergoing extensive clinical validation across more than ten hospitals and partner institutions, including Shenzhen People’s Hospital, the Guangzhou First Municipal People's Hospital, and Yunnan Cancer Center, to validate its effectiveness and ensure real-world applicability. Harnesses China’s largest mpMRI Dataset

The Hong Kong University of Science and Technology (“HKUST”) has partnered with Esquel Enterprises Limited (“Esquel Group”) to launch a five-year study program that allows HKUST students to conduct biannual field research at the textile manufacturer’s 500,000-square-meter Sustainable Development Garden Integral, recognized as one of China’s top 20 sustainable development projects by the United Nations.  Guided by HKUST faculty, students will visit the garden twice a year in groups to assess and make recommendations regarding its sustainability impact on environmental monitoring and biodiversity conservation.  This initiative marks another academic-industry collaboration aimed at accelerating the Greater Bay Area’s transition to a low-carbon economy.

The Hong Kong University of Science and Technology (HKUST) has received a generous donation from the Ho Iu Kwong Charity Foundation (the Foundation) to enhance student development and campus life. In appreciation of this benevolent support, HKUST has named the UG Student Hall III in honor of Mr. Ho Iu Kwong and his wife, Ms. Kwok Pui Chun.  Mr. HO Sai-Chu, eldest son of the late philanthropist and Chairman of the Foundation, attended the naming and plaque unveiling ceremony for the Ho Iu Kwong and Kwok Pui Chun Hall, joined by his family members, the Foundation’s representatives, and HKUST senior management. The late Mr. HO Iu Kwong, founder of Fook Lee Construction Company Ltd, was a distinguished business figure who made significant contributions to education and society.  

The Hong Kong University of Science and Technology (HKUST) has renewed its Memorandum of Understanding (MoU) with the Consulate General of France in Hong Kong and Macau (French Consulate General) for the third time, deepening eight-year collaboration. This agreement strengthens joint efforts to address global sustainability challenges, which include the Anita Conti Sustainable Innovation Fellowship, an initiative designed to foster the development of the next generation of researchers, innovators, and environmentalists, equipping them to tackle the pressing challenges of climate change and its global impacts.

The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today.  As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for hundreds of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.  

Two healthtech innovators nurtured by The Hong Kong University of Science and Technology (HKUST) - PanopticAI Limited (PanopticAI) and SmartCare Technology Co Limited (SmartCare), have entered a landmark collaboration with Gleneagles Hospital Hong Kong (Gleneagles). Witnessed by Prof. Nancy IP, President of HKUST; Dr. Prem Kumar NAIR, Group Chief Executive Officer of IHH Healthcare; and Dr. Patrick LAU, Deputy Executive Director of Hong Kong Trade Development Council (HKTDC), the tripartite collaboration agreement signing marks a strategic effort to deploy AI-powered smart clinic solutions at Gleneagles MediCentre, set to launch in late 2025. The partnership exemplifies the commitment of both HKUST and Gleneagles to translating research excellence into real-world applications with a view to facilitating healthcare advancements through the University’s robust entrepreneurship ecosystem.

香港科技大學（科大）近日與山東兩大醫藥上市公司：綠葉製藥集團（綠葉製藥）與博安生物技術股份有限公司（博安生物）簽署合作協議，共同推動生物醫藥領域的前沿協作、成果轉化及人才培育，以支持科大發展醫療科技及申辦「香港生命健康研發院」等策略舉措。 深化前沿醫藥研究及人才培育合作 綠葉製藥是專注於創新藥物研發的領先中國醫藥企業，近年於中國內地、歐美、日本等主要醫藥市場成功上市13款新藥，在中樞神經系統（CNS）治療領域居領先地位。其子公司博安生物則是一家全面綜合性生物製藥公司，特別聚焦研發腫瘤、自身免疫、眼科和代謝疾病新藥及治療方法。根據協議內容，科大將與兩所企業就臨床前及臨床研究、前沿科學領域探索、人才培訓及交流和科研成果産業化等範疇展開深度協作。 其中，科大與博安生物將特別聚焦開發新型抗癌藥物和癌症新療法；與綠葉製藥則會集中研究神經科學與中樞神經系統疾病的新療法，以及先進藥物遞釋系統。此外，兩家企業亦將支持科大培育醫藥創新領域人才，為學生提供研究和實踐的產業基地，並提供相關科研技術落地應用平台。  科大副校長（研究及發展）鄭光廷教授樂見與兩間公司達成多領域合作，他表示：「科大一直致力推動科研成果產業化，積極搭建從實驗室走向市場的完善產業鏈。我們長期深耕生物醫藥領域的創新研究，近年更積極拓展醫療創新合作網絡。我們期待，透過結合AI與生物醫學的交叉優勢，科大可與兩家企業攜手協作，進一步推高產業化能力，並共同探索智能藥物開發、數據驅動的臨床研究等前沿方向，加速創新成果落地轉化，為全球帶來更精準、高效的醫療方案。」

The global transdisciplinary "research-to-operation" (R2O) initiative, “Seamless Prediction and Services for Sustainable Natural and Built Environments” (SEPRESS), led by The Hong Kong University of Science and Technology (HKUST), has been endorsed by the United Nations Educational, Scientific and Cultural Organization (UNESCO) as part of its International Decade of Sciences for Sustainable Development (IDSSD). Over the next decade, HKUST’s SEPRESS will spearhead efforts to collaborate with global partners in transforming scientific advancements into tailored solutions that enhance climate resilience and sustainability worldwide, with a particular focus on Least Developed Countries. SEPRESS will achieve this by translating progress in weather-to-climate prediction research into scalable solutions and fostering global partnerships to deliver actionable outcomes.